Management strategies for candidates for protease inhibitors and requiring treatment for Mycobacterium tuberculosis. TB/HIV Advisory Committee.

  • Dr. Fraser Ashton
  • Published 1998 in
    Canada communicable disease report = Releve des…
Although co-infection with HIV and TB has not been a major problem in Canada, there are indications of increasing rates of HIV-related TB. This is especially true for high-risk groups, including intravenous drug users. The availability of protease inhibitors, a potent new antiretroviral therapy, and their documented interaction with rifamycin-type… (More)